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Apoptosis and extracellular matrix–cell interactions in kidney apoptosis in the glomerulosclerosis of animal models and
disease. Extracellular matrix (ECM)–cell interactions have ma- human renal diseases, concentrates on the regulation of
jor effects on phenotypic features such as cell growth, differen- apoptosis by extracellular matrix (ECM), and considerstiation, and gene expression. Apoptosis is an active form of
how this type of cell death might be involved in diabeticcell death that is crucial for maintaining an appropriate number
renal disease processes.of cells as well as tissue organization. Recent reports have
implied that ECM can influence survival and apoptosis of sev-
eral cell lineages including glomerular mesangial cells (MC).
Numerous glomerular diseases are associated with the expan- CELL DEATH: APOPTOSIS AND NECROSIS
sion of the mesangial ECM, which may eventually produce
Apoptosis is a specific type of cell death that is crucialglomerular scarring. Glomerular cell apoptosis is associated
for maintaining an appropriate number of cells as wellwith the deletion of glomerular cells and the accumulation of
ECM in the progression of glomerulosclerosis in rat remnant as the organization of tissue [2, 3]. The early stage of
kidney model induced by 5/6 nephrectomy. Our recent study apoptosis is characterized by compaction and margina-
indicated that basement membrane matrix (a model for normal tion of nuclear chromatin, condensation of cytoplasm,ECM components) prevented cultured MC from undergoing
and nuclear fragmentation. Characteristic apoptosis be-apoptosis after serum deprivation, thus promoting their sur-
gins by degrading DNA into small fragments of oligo-vival, compared with type I collagen matrix (a model for abnor-
mal ECM components). Inhibition of matrix-derived signals nucleosomes [7]. Induction of endogenous cysteine pro-
by antisense oligonucleotides against b1 integrin increased MC teases called caspases leads to endonuclease activation
apoptosis. Data suggest that the survival and death of MC are
contributing such DNA fragmentation [8–10]. This re-regulated by the surrounding ECM through integrin molecules.
sults in disruption of the cytoskeleton, cell shrinkage,The mechanism of regulation of MC apoptosis by ECM re-
quires further in vivo study to gain new insight into the treat- and membrane blebbing to form apoptotic bodies. The
ment of glomerular diseases as well as the pathophysiology of dying cell maintains the integrity of its plasma mem-
the mesangium. Diabetic nephropathy is characterized by the brane. Alterations of the plasma membrane, including
abnormal ECM accumulation and the phenotypic change of
exposure of the anionic phospholipid phosphatidylserineMC. Some speculations on the possible involvement of apopto-
and others, signals neighboring phagocytic cells to recog-sis in diabetic nephropathy are also discussed.
nize and engulf it [11, 12]. Apoptotic bodies are finally
degraded within lysosomes of neighboring cells, which
prevents injury of surrounded tissues from the dischargeCell life always requires cell death. The word apoptosis
in Greek means the “dropping off” or “falling off” of of deleterious cytoplasmic contents [11, 12]. Conversely,
leaves from trees [1]. By inference, this suggests that early necrosis shows irregular clumping of chromatin
apoptosis is a physiologic and programmed form of cell and swelling of all cytoplasmic compartments. At a later
death. However, published reports have suggested that stage of necrosis, the cell membrane disrupts. The ne-
increased or decreased apoptosis may have a pathologic crotic cell degenerates to form debris and provokes in-
role in several human diseases [2, 3] including those flammation around the cell.
relating to the kidney [4–6]. This paper briefly describes Given the lack of definitive molecular markers for
the features of apoptosis, focuses on the occurence of immunostaining of apoptosis, morphologic and ultrastruc-
tural examination with electron microscopy is the most
definitive method to confirm the type of cell death. Elec-
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tron microscopic examination, however, has a limitationdiabetes, high glucose, diabetic nephropathy, advanced glycation end
products. in terms of observation. Several enzymatic techniques
have been developed to detect DNA fragmentation atÓ 2000 by the International Society of Nephrology
S-67
Makino et al: Apoptosis and ECMS-68
the cellular level on tissue sections to quantify apoptosis that apoptosis is involved in reduction of acute glomeru-
lar injury, which allows a hypercellular glomerulus to[13–16]. Terminal deoxynucleotidyl transferase (TdT)-
mediated dUTP-biotin nick-end labeling (TUNEL) was return to normal. Savill et al reported that neutrophil
apoptosis leads to its recognition and phagocytosis notused to detect glomerular cell apoptosis in previous stud-
ies [17–22]. TdT incorporates nucleotides from the 39 only by inflammatory macrophages but also by resident
glomerular mesangial cells (MC) in nephrotoxic nephri-OH-terminus into fragmented DNA of apoptotic cells
[14]. Clinicians might express concern that this molecular tis in rats [29, 30]. Baker et al [17] and Shimizu et al [18]
have reported that apoptosis was the major mechanismtechnique detects not only apoptotic DNA but also ran-
dom DNA fragmentation that occurs in late stages of in the resolution of glomerular hypercellularity in Thy1.1
glomerulonephritis. They also demonstrated that MCnecrosis [16]. Therefore, TUNEL method should be
apoptosis may be engaged as a homeostatic mechanismcombined with an analysis of nuclear morphology as
that controls the size of the glomerular cell populationreported in our examination of the conventional hema-
and clears overproliferated MC. These studies suggesttoxylin and eosin stain on the serial section.
that deletion of unwanted or surplus cells by apoptosis
may be beneficial for the glomerulus in self-limited pro-
APOPTOSIS IN DISEASE liferative glomerulonephritis. In other types of tissue,
Apoptotic cell death is an active, energy-dependent, myofibroblasts are deleted by apoptosis during wound
and programmed form of cell death that plays a crucial healing of the skin [31]. Both MC in injured glomeruli
role in physiologic processes such as embryogenesis, en- as well as fibroblasts in injured skin acquire myofi-
docrine- or cytokine-dependent tissue atrophy, and nor- broblast-like phenotypes such as de novo expression of
mal cell turnover. Cell count in the tissue is determined a–smooth muscle actin [32, 33]. Apoptosis may be the
by the balance between the rates of cell division by mito- common mechanism through which hyperplastic tissue
sis and cell death by apoptosis [3]. In the absence of returns to normal after injury.
compensatory changes in the rate of cell proliferation However, apoptosis may also play a pathologic role
or mitosis, changes in the rate of apoptosis cause either that is not beneficial for the tissue in relationship to
cell accumulation or cell loss. Clearly, various diseases certain neurodegenerative disorders [34] and forms of
are associated with increased or decreased apoptosis ischemic injury [35]. In the presence of global sclerosis,
[2, 3]. Excessive apoptosis may be involved in the ac- glomerular cells are depleted and the glomeruli are re-
quired immune deficiency syndrome, neurodegenerative placed by the ECM. Glomerulosclerosis may thus be
disorders, myelodysplastic syndrome, ischemic injury, regarded as a process involving progressive decrease in
and toxin-induced liver disease, although underlying de- the number of resident and extrinsic glomerular cells
as well as an increase in glomerular ECM. The basicfects in control of apoptosis have not been defined in
mechanisms of this progressive loss of cells remain un-most diseases. Decreased apoptosis may also be related
known. Several years ago, we initially hypothesized thatto the progression of cancers, autoimmune disorders,
apoptosis might be involved in the glomerular cell lossand viral infections. In these situations, apoptosis may
of progressive glomerular scarring. This hypothesis wasplay a role in the pathogenesis of disease. These diseases
applied in the experimental remnant kidney model inare characterized by the accumulation of cells resulting
rats and in human renal biopsy specimens from patientsfrom either increased proliferation or decreased apopto-
with glomerulonephritis including IgA nephropathy andsis in response to appropriate stimuli.
lupus nephritis [20, 36]. In this study, we found a signifi-
cant increase of apoptotic cells in the glomeruli of 5/6
APOPTOSIS IN GLOMERULAR SCLEROSIS nephrectomized rats compared with sham-operated rats
Apoptosis in the field of nephrology was initially inves- [20]. The increase in glomerular cell apoptosis was associ-
tigated in the mechanism of tubular injuries [23–25]. Cell ated with glomerular cell deletion and ECM accumula-
deletion by apoptosis in tubular atrophy in experimental tion in the late stages of glomerulosclerosis after the
hydronephrosis [23] and tubular epithelial cell apoptosis early transient cell proliferation in the rat remnant kid-
in renal ischemia and subsequent reperfusion injury [24– ney model. In this model, the number of glomerular
26] have been reported. Apoptosis seems to be involved apoptotic cells increased with the progression of glomer-
in the pathogenesis of tubular damage in these settings. ular sclerosis. In human glomerulonephritis including
Cell death has been documented in a diseased glomer- lupus nephritis and IgA nephropathy, apoptotic cells
ulus [27–30]. Harrison first reported the presence of apo- were visualized in the glomeruli. The number of glomer-
ptotic bodies in human glomerulonephritis by both light ular apoptotic cells correlated with the glomerular sclero-
and electron microscopy [27]. He identified numerous sis index and deterioration of renal function in human
neutrophils undergoing apoptosis in severe proliferative nephritis. We also recognized TUNEL-positive cells in
glomeruli of patients with focal and segmental glomeru-glomerulonephritis. The observation led to speculation
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Fig. 1. Apoptosis in the mesangium in glomeruli of 5/6 nephrectomized rats. An electron micrograph of the glomerulus from a remnant kidney
rat at 8 weeks after disease induction is shown. A fragmented nucleus with condensed chromatin (*) is surrounded by collagen fibers (arrows) in
the sclerotic lesion in the mesangium. GBM, glomerular basement membrane. Magnification 322,000.
losclerosis (unpublished observations). These results sug- MESANGIAL CELL APOPTOSIS AND
gest that apoptosis is, at least in part, one mechanism of ECM–CELL INTERACTION
glomerular cell deletion during progressive glomerular The factors that regulate apoptosis of MC in progres-
sclerosis [20]. Moreover, apoptosis may also play a patho- sive glomerular scarring remain undefined. We found
logic role that is not always beneficial for the glomerulus. that MC apoptosis occurs during changes and remodel-
Studies by Shimizu et al also support this concept [19]. ing of the glomerular ECM in the experimental model
The renal glomerulus is composed of three types of of glomerulosclerosis in rats (Fig. 1) and in human glo-
resident cells, the glomerular mesangial, endothelial, and merulonephritis [20]. Therefore, we hypothesized that
epithelial cells [37]. In addition, leukocytes infiltrate the normal ECM may support the survival of MC and pre-
inflamed glomerulus. Because the morphology of the vent their death and that changes in ECM constituents
apoptotic cell is uniform regardless of cell type, it is
may decrease the survival signals to MC and thus in-
difficult to typify particular apoptotic cells [1, 38, 39].
crease their susceptibility to stimuli that induce apopto-Moreover, apoptotic cells are so rapidly phagocytosed
sis. We initially investigated differences in the suscepti-and ingested that they do not maintain their original
bility to apoptotic stimuli of MC cultured on variousstructures and distinctive markers of cell origin [11, 12].
ECM components. We then evaluated whether the inhi-We can presume the origin of apoptotic cells based on
bition of MC–matrix interactions by antisense oligonu-where the lesions are located in the glomerulus. We also
cleotides against b1 integrin mRNA would affect thedemonstrated that apoptosis occurred in the glomerular
apoptosis in MC. Our study showed that basement mem-mesangium with ECM accumulation (Fig. 1) but not in
brane matrix prevented MC from undergoing apoptosisthe glomerular capillaries using both light and electron
and promoted the survival of MC after serum depriva-microscopy. This observation suggests that at least one
tion, as compared with type I collagen or fibronectinof these apoptotic cells is a mesangial cell. The mecha-
matrix [42]. Inhibition of matrix-derived signals by anti-nism of glomerular cell loss in progressive glomeruloscle-
sense ODN for b1 integrin increased apoptosis in MCrosis has been given minimal attention. Our study for
after serum deprivation. Thus, MC survival and deaththe first time demonstrates apoptosis to be involved in
may be regulated by ECM via b1 integrin molecules ofthis process. Our hypothesis of possible involvement of
cell surface receptors.MC apoptosis and ECM–cell interactions in glomerular
scarring is shown in Fig. 2 [40, 41]. Mesangial ECM not only provides structural support
Makino et al: Apoptosis and ECMS-70
Fig. 2. Hypothetical schema of possible in-
volvement of mesangial cell apoptosis and ma-
trix–cell interactions in glomerular scarring.
ECM, extracellular matrix; ROS, reactive oxy-
gen species; NO, nitric oxide.
of the glomerular capillary tuft but also plays a more the mesangium, as well as to de novo expression of inter-
stitial type I collagen [58]. The levels of type I collagenactive role by affecting adhesion, migration, prolifera-
mRNA and protein peaked on day 5 and decreasedtion, and differentiation of MC [43–46]. Earlier studies
thereafter. The peak in MC apoptosis was reportedlyhave suggested that ECM can influence survival and
seen on day 5 in the same model [17]. These data furtherapoptosis of several types of cells [47–53]. Numerous
support an association between mesangial apoptosis andglomerular disorders are associated with an expansion
changes in the components of the ECM.of the mesangial ECM, which may eventually result in
Cell–matrix interactions are mediated by the adhesionglomerular scarring [54–56]. Current studies demon-
molecules [59, 60]. The integrins are a major family ofstrate that MC apoptosis is important in glomerular dis-
cell surface receptors that mediate attachment to theeases [17, 18, 20]. Our earlier paper reported that apopto-
ECM [60–62]. They are heterodimeric transmembranesis is associated with the deletion of glomerular cells and
glycoproteins that consist of various combinations ofthe accumulation of ECM in the progression of glomeru-
noncovalently bound a and b chains. In all, 16 a and 8losclerosis in the remnant kidney model induced by 5/6
b chains have been described to date [63]. The a subunitnephrectomy [20]. After the initial low-grade prolifera-
largely determines substrate specificity with the ECMtion of MC, a progressive development of glomeruloscle-
proteins [64], whereas the intracytoplasmic tail of therosis was noted in this model. Floege et al reported that
b-chain is mainly responsible for its interaction with thethe increased ECM components included type IV colla-
cell cytoskeleton [65]. The b1 subunits contain sites ofgen, laminin, fibronectin, and heparan sulfate proteogly-
tyrosine phosphorylation in the cytoplasmic domain, sug-can, which are normally within the mesangium [57]. An-
gesting they might have a potential role in signal trans-other important finding was de novo expression of type
duction [59, 62]. We studied the signal for the prevention
I collagen mRNA and protein, which are not normally of apoptosis by blocking of b1 integrin. The normal mes-expressed in the glomerulus [57]. They observed focal angium has various b1 and avb3 integrins and cell surfaceincreases in mesangial staining for type I collagen at proteoglycans (Table 1) [44, 45, 66, 67]. Changes in integ-
week 4 of their study and the expanded glomerular stains rin expression in glomerular disease have been reported
at week 10. We observed a significant increase in the num- [68]. Expression of b1 integrin decreases within areas
ber of glomerular cells undergoing apoptosis at week of glomerular scarring (abstract; Hillis et al, J Am Soc
8 in the same model [20]. These findings suggest that Nephrol 6:896, 1995). At present, it remains unclear
apoptosis of MC might be controlled by their surrounding which of the b1-containing integrins promote MC sur-
matrix in progressive glomerulosclerosis in vivo. vival. Distinct b1 integrins can mediate cell survival in
It has also been reported that mesangial apoptosis is mammary epithelial cells and Chinese hamster ovary
the major mechanism of cell clearance and that it medi- cells, whereas avb3 integrin can mediate survival of vascu-
ates the resolution of glomerular hypercellularity in lar endothelial cells and melanoma cell survival in three-
Thy1.1 glomerulonephritis [17, 18]. As in the remnant dimensional collagen [50–52, 69, 70]. The integrin re-
kidney model, increased mesangial matrix results in part quired for cell survival and integrin-dependent survival
signals may be specific for cell lineages.from ECM components that are normally present within
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Table 1. Extracellular matrix receptors in glomerular mesangial cells Table 2. Factors promoting glomerular mesangial cell
apoptosis/survival in vitro
Integrins
b1 a1 Factors
a2
Apoptosis
a3
Serum withdrawal
a4
Reactive oxygen species
a5
Nitric oxide
a6
Fas ligation
a7
Anti-Thy 1.1 antibodies
a8
Anti-double stranded DNA antibodies
b3 av Tumor necrosis factor-aCell surface proteoglycans
Interleukin-1aSyndecan 4
Ionizing radiationCD44
Cytotoxic drugs
Cyclic AMP
Shear stress
Survival
Insulin-like growth factor-I
In most tissues, cell survival depends on a constant Extracellular matrix
Basement membrane matrixsupply of survival signals provided by the neighboring
Type IV collagencells and the ECM [47–53, 71, 72]. Many types of cultured
Laminin
cells undergo apoptosis in the absence of specific survival
factors. Almost all cells may be programmed to commit
suicide if they do not receive adequate survival signals
from the environment. It has been suggested that MC
tein, type IV collagen, occurs in early diabetic glomerulo-
undergo apoptosis unless they receive a sufficient supply
sclerosis. In later stages, however, the minor collagen
of survival factors [17], including some cytokines and
components such as type V and VI collagens and fibrilgrowth factors [73]. Our data indicate that ECM is one
and interstitial collagens such as type III collagen increaseof the important regulators of MC survival [42]. The
in diabetic glomerulosclerosis [95]. MC are known tocapacities of ECM to protect against apoptosis may result
produce all these collagens through their phenotypicfrom differences in the degree of attachment to the ma-
changes after glomerular injury [32]. The phenotypictrix. Growth factor–reduced basement membrane matrix
change of the MC is considered to play a pivotal role inhas a much reduced level of various growth factors such
the accumulation of ECM in diabetic nephropathy [96].as insulin-like growth factor-I, a candidate survival factor
In diabetes, phenotypic change of MC may synthesizefor MC [73]. It might contain a certain amount of matrix-
excess amount of fibril and interstitial collagens such asbound cytokines and might be responsible for the sur-
types III, IV, and V collagens, and thus lead to glomeru-vival effect. It is suggested that not only basement mem-
losclerosis [95, 97]. Heparan sulfate proteoglycans in thebrane matrix but also each matrix molecule (laminin and
glomerular basement membrane are reduced in patientstype IV collagen) can promote survival of MC (Table 2)
with diabetic nephropathy [98]. This may result in the al-[74]. Our data thus suggest that the survival and death of
teration of charge barrier of glomerular basement mem-the MC are regulated by the surrounding ECM through
branes and may thus, at least in part, cause the protein-integrin molecules. Although factors regulating survival/
uria associated with diabetic nephropathy [99].apoptosis of MC have been identified in vitro (Table 2)
Development of diabetic nephropathy is linked to hy-[17, 21, 42, 73–93], the mechanism of MC survival and
perglycemia [100]. High glucose itself can induce DNAdeath requires further in vivo study to gain new insight
fragmentation in vascular endothelial cells. Glucose caninto the treatment of glomerular diseases as well as the
react nonenzymatically with proteins to form Schiff base,pathophysiology of the mesangium.
Amadori products, and advanced glycation end products
ECM change and advanced glycation end products in (AGEs) characterized by fluorescence, brown pigmenta-
diabetic nephropathy tion, and cross linking [101]. Formation of normal ECM
depends on a geometrically ordered self-assembly pro-Diabetic nephropathy is one of the major complications
cess with site-specific, end-to-end, and lateral interac-that determine the outcome of patients with diabetes
tions of ECM macromolecules [102]. AGE modification[94]. It is characterized clinically by an elevated glomeru-
of ECM components may induce an alteration of struc-lar filtration rate and development of microalbuminuria
ture and impairment of self association of ECM in vivo.at its early stage followed by overt proteinuria and pro-
The major lesion of diabetic nephropathy, glomerulargressive renal failure. It is distinguished histologically by
nodular lesion, is an expansion of mesangial matrix with-glomerular hypertrophy, glomerular basement membrane
out evidence for proliferation of MC. We found thatthickening, mesangial matrix expansion, and final glo-
merulosclerosis. Accumulation of the normal matrix pro- Ne-carboxy-methyllysine, one of several glycoxidation
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products, is immunohistochemically localized to nodular
lesions of patients with diabetic glomerulosclerosis [103].
The looser meshwork structures of these lesions were
visualized using high-resolution scanning electron mi-
croscopy. Thus, we concluded that AGEs might play a
role in the progression of diabetic nephropathy through
impairment of the assembly of matrix proteins in vivo
[96]. It has been reported that nonenzymatic glycation
of matrix with either glucose-6-phosphate or glycolalde-
hyde inhibited rat MC proliferation in vitro and that this
effect was partially reversed by aminoguanidine [104].
Glycation of collagen with glucose-6-phosphate abol-
ished the inhibitory effect of collagen on proliferation
of human vascular smooth muscle cells in vitro and may
Fig. 3. TdT-mediated DNA nick end-labeling (TUNEL) of tubulesthus participate in the progression of macroangiopathy
from streptozocin-induced diabetic rats at 24 weeks after disease induc-
in diabetes. tion. There are clusters of TUNEL-positive cells desquamated in the
tubular lumen. Magnification, 3400.Because ECM can directly or indirectly affect several
cell phenotypes [59, 60, 62, 105, 106], these ECM changes
and modification of ECM with AGEs observed in dia-
betic glomerulosclerosis might have some effects on MC
factors; the intracellular signaling pathways through thedeath or survival as in forming an acellular nodular le-
receptors; how these pathways activate or suppress apo-sion, one of the characteristic findings in diabetic ne-
ptosis; and how the amount of each pro-apoptotic/sur-phropathy, although we have no evidence for this as yet.
vival factor is controlled. In another view, some candi-
date pro-apoptotic/survival factors (Table 2) shouldApoptosis in diabetic tubular injury
complete Koch’s postulates in establishing a role for plate-Apoptosis in diabetic nephropathy has been studied
let-derived growth factor-B and transforming growth fac-in the context of tubular injury [107, 108]. Administration
tor-b as mediators of MC proliferation and mesangialof a high glucose solution into rats induced DNA frag-
matrix expansion, respectively, as suggested by Johnsonmentation in the proximal tubular epithelial cells in vivo
and Lovett [110]. Much work remains to be done in the[107]. DNA fragmentation may be associated with renal
new millennium but following such an approach mayproximal tubular damage in the early stage of diabetic
allow researchers to develop a novel therapeutic strategytubular injury. Ortiz et al reported a significant increase
manipulating apoptosis in renal diseases.
in apoptosis in the tubulointerstitium but not in glomer-
uli of db/db mice compared with nondiabetic controls
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